Mitchell Sinkler & Starr’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Hold |
2,800
| – | – | 0.1% | 136 |
|
|
2025
Q1 | $203K | Hold |
2,800
| – | – | 0.06% | 151 |
|
|
2024
Q4 | $207K | Buy |
+2,800
| New | +$207K | 0.06% | 154 |
|
|
2024
Q3 | – | Sell |
-2,800
| Closed | -$240K | – | 191 |
|
|
2024
Q2 | $240K | Buy |
+2,800
| New | +$240K | 0.06% | 140 |
|
|
2023
Q3 | – | Sell |
-2,800
| Closed | -$264K | – | 109 |
|
|
2023
Q2 | $264K | Hold |
2,800
| – | – | 0.08% | 127 |
|
|
2023
Q1 | $232K | Hold |
2,800
| – | – | 0.07% | 133 |
|
|
2022
Q4 | $209K | Buy |
+2,800
| New | +$209K | 0.07% | 136 |
|
|
2021
Q1 | – | Sell |
-3,750
| Closed | -$342K | – | 102 |
|
|
2020
Q4 | $342K | Hold |
3,750
| – | – | 0.33% | 76 |
|
|
2020
Q3 | $299K | Hold |
3,750
| – | – | 0.3% | 78 |
|
|
2020
Q2 | $259K | Buy |
+3,750
| New | +$259K | 0.29% | 83 |
|
|
2020
Q1 | – | Sell |
-3,150
| Closed | -$245K | – | 97 |
|
|
2019
Q4 | $245K | Buy |
+3,150
| New | +$245K | 0.26% | 89 |
|